Collegium Pharmaceutical Inc. (NASDAQ: COLL) announced it will acquire AZSTARYS, an attention deficit hyperactivity disorder treatment, from privately held Corium ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE